Biocon withdraws application for EU approval of two drugs
EU drugs regulator sought re-inspection of their production facility
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Biocon
Mylan and Biocon to present phase-III trastuzumab biosimilar data at ASCO annual meeting
HERITAGE study shows comparable efficacy, safety and immunogenicity to branded trastuzumab in HER2-positive metastatic breast…
Biocon to invest Rs 1,060 crores in Bengaluru plant
The facility is expected to generate at least 750 jobs immediately
Delhi HC refrains from staying single judge interim order over breast cancer drug by Biocon and…
The division bench of the high court, however, said the drug-makers may continue to sell their products under the brand names
Biocon’s Insulin Glargine receives regulatory approval in Japan
The product is ready to be launched in Q1 FY17
Biocon in co-development and commercialisation agreement with Lab PiSA
The collaboration is part of Biocon’s strategy to address the large demand for generic rh-insulin in the US
Biocon receives first generic formulation approval in EU
The approval will enable the company to address $1.2 billion opportunity, starting FY17
Biocon has received European approvals…
Biocon acquires Acacia Lifesciences’ manufacturing plant
The facility, which is spread over 45,000 square feet, was commissioned in 2008